Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time
Crossref DOI link: https://doi.org/10.1007/s00228-022-03386-z
Published Online: 2022-09-13
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tung, Norint P.
Ma, Joseph D.
Text and Data Mining valid from 2022-09-13
Version of Record valid from 2022-09-13
Article History
Received: 15 July 2022
Accepted: 7 September 2022
First Online: 13 September 2022
Declarations
:
: The authors declare no competing interests.